MedPath

Myopia Control With Three Lever Irradiance of PBM Therapy in Children and Adults

Not Applicable
Completed
Conditions
Myopia
Amblyopia
Refractive Error - Myopia Axial
Ametropia
Interventions
Device: Airdoc device of red light for Myopia
Registration Number
NCT05957458
Lead Sponsor
Beijing Airdoc Technology Co., Ltd.
Brief Summary

Photobiomodulation therapy, that is, Low-level red-light technology provides a new and innovative myopia control approach. This strategy enables relatively high energies of light to be delivered at much shorter durations of exposure to induce the myopia control effect. The efficacy of the low-level red-light technology has been proven in a Chinese populationb for the recent 3 years with evidence based papers and amazing results. However, there's not yet evidence to demonstrate the relationship between the dose response effect of photobiomodulation therapy on myopia control at the different age lever.

Detailed Description

Previous trial has demonstrated that 3-minutes per session twice a day repeated low-level red-light treatment at the irridiance of 2.3mW(2.0\~2.5mW) controlled 87.7% of refraction progression and 76.8% of axial length elongation when the time of compliance to the treatment was 75%. Retrospective analyze other irriadance of 1.2mW, 0.6mW and 0.37mW culturally diverse groups will confirm and translate this technology into a solution for myopia control globally.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Myopia or near Myopia with younger age
  • Without other intervention of myopia control, including atropine, Misight contact lens, special design lens to control myopia, orthokeratology and other red light devices.
  • Follow-up at least once
  • With baseline data of ocular parameters before the follow-up
Exclusion Criteria
  • Photophobia
  • Allergy to red light
  • Severe ocular progressing diseases or systemic diseases
  • The data is unacceptable with reasonable explanations

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Extra low irradiance PBM therapy groupAirdoc device of red light for MyopiaThe PBM therapy irradiance is about 0.37mW. It is asked subjects to look at the light binocularly with fusion through the pupils with natural pupils. The distance between the light and the pupils is about 5\~10cm. The treatment of each session is 3 minutes and twice daily administration while the interval time between two session is equal or larger than 4 hours with twice daily administration.
Moderate irradiance of PBM therapy to myopiaAirdoc device of red light for MyopiaThe PBM therapy irradiance is about 0.60mW. It is asked subjects to look at the light binocularly with fusion through the pupils with natural pupils. The distance between the light and the pupils is about 5\~10cm. The treatment of each session is 3 minutes and twice daily administration while the interval time between two session is equal or larger than 4 hours with twice daily administration.
high lever PBM therapy groupAirdoc device of red light for MyopiaThe PBM therapy irradiance is about 1.20mW. It is asked subjects to look at the light binocularly with fusion through the pupils with natural pupils. The distance between the light and the pupils is about 5\~10cm. The treatment of each session is 3 minutes and twice daily administration while the interval time between two session is equal or larger than 4 hours with twice daily administration.
Primary Outcome Measures
NameTimeMethod
Axial length shortening comparing to that value of baseline (mm)6-month

Measured with optial coherent methods with the same device assistant with the same techinician

Secondary Outcome Measures
NameTimeMethod
Refractive changes at the follow-up from the baseline (D)12-month

Spherical Equivalence were recorded with the right eyes only

Trial Locations

Locations (1)

Qiu Jenny

🇨🇳

Beijing, Haidian District, China

© Copyright 2025. All Rights Reserved by MedPath